Literature DB >> 23053338

[Orbital neoplasia. Part I: Introduction, vascular and neurogenic tumors].

M P Schittkowski1, N Fichter.   

Abstract

Tumors of the orbit are rare but the huge variability of clinical symptoms and findings are challenging for the ophthalmologist who is frequently contacted as the first resort. If the patient history and clinical findings are suspicious for an orbital mass the result of the initial examination should allow a rough estimation of localization (intra/extraconal), type of growth (expansive/infiltrative), dignity (vascular/solid etc.) and threat to visual functions. An adequate initial diagnostic pathway enables a precise question to the radiologist to be formulated and selection of the disciplines required for an interdisciplinary workup and therefore for early treatment.

Entities:  

Mesh:

Year:  2012        PMID: 23053338     DOI: 10.1007/s00347-012-2664-2

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  18 in total

Review 1.  Percutaneous treatment of low flow vascular malformations.

Authors:  Patricia E Burrows; Keira P Mason
Journal:  J Vasc Interv Radiol       Date:  2004-05       Impact factor: 3.464

2.  Propranolol for severe hemangiomas of infancy.

Authors:  Christine Léauté-Labrèze; Eric Dumas de la Roque; Thomas Hubiche; Franck Boralevi; Jean-Benoît Thambo; Alain Taïeb
Journal:  N Engl J Med       Date:  2008-06-12       Impact factor: 91.245

3.  Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.

Authors:  N Lau; M M Feldkamp; L Roncari; A H Loehr; P Shannon; D H Gutmann; A Guha
Journal:  J Neuropathol Exp Neurol       Date:  2000-09       Impact factor: 3.685

4.  Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).

Authors:  A K Gnekow; R-D Kortmann; T Pietsch; A Emser
Journal:  Klin Padiatr       Date:  2004 Nov-Dec       Impact factor: 1.349

5.  Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome.

Authors:  Christine J Schupp; Johann-Baptist Kleber; Patrick Günther; Stefan Holland-Cunz
Journal:  Pediatr Dermatol       Date:  2011-10-13       Impact factor: 1.588

Review 6.  Hemangioblastoma of the optic nerve: case report.

Authors:  D J Kerr; B W Scheithauer; G M Miller; M J Ebersold; T J McPhee
Journal:  Neurosurgery       Date:  1995-03       Impact factor: 4.654

7.  Fractionated beta-irradiation of a conjunctival lymphangioma.

Authors:  S Behrendt; H Bernsmeier; G Randzio
Journal:  Ophthalmologica       Date:  1991       Impact factor: 3.250

8.  Hemangiopericytoma of the orbit: a clinicopathologic study of 30 cases.

Authors:  J O Croxatto; R L Font
Journal:  Hum Pathol       Date:  1982-03       Impact factor: 3.466

9.  Embolization of orbital varices with N-butyl cyanoacrylate as an aid in surgical excision: results of 4 cases with histopathologic examination.

Authors:  Steven M Couch; James A Garrity; J Douglas Cameron; Harry J Cloft
Journal:  Am J Ophthalmol       Date:  2009-07-09       Impact factor: 5.258

10.  Surgical management of orbital lymphangioma with the carbon dioxide laser.

Authors:  J S Kennerdell; J C Maroon; J A Garrity; A A Abla
Journal:  Am J Ophthalmol       Date:  1986-09-15       Impact factor: 5.258

View more
  2 in total

1.  [Orbital neoplasia. Part II: mesenchymal, leukemic, lymphoproliferative and bony tumors, metastasis].

Authors:  M P Schittkowski; N Fichter
Journal:  Ophthalmologe       Date:  2013-01       Impact factor: 1.059

Review 2.  Rare Diseases of the Orbit.

Authors:  Ulrich Kisser; Jens Heichel; Alexander Glien
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.